Search Results

There are 9442 results for: content related to: The clinical phenotype of wild-type, heterozygous, and homozygous JAK2 V617F in polycythemia vera

  1. You have free access to this content
    JAK2 V617F uses distinct signalling pathways to induce cell proliferation and neutrophil activation

    British Journal of Haematology

    Volume 150, Issue 3, August 2010, Pages: 334–344, Seido Oku, Katsuto Takenaka, Takuro Kuriyama, Kotaro Shide, Takashi Kumano, Yoshikane Kikushige, Shingo Urata, Takuji Yamauchi, Chika Iwamoto, Haruko K. Shimoda, Toshihiro Miyamoto, Koji Nagafuji, Junji Kishimoto, Kazuya Shimoda and Koichi Akashi

    Version of Record online : 10 JUN 2010, DOI: 10.1111/j.1365-2141.2010.08249.x

  2. You have free access to this content
    JAK2V617F monitoring in polycythemia vera and essential thrombocythemia: Clinical usefulness for predicting myelofibrotic transformation and thrombotic events

    American Journal of Hematology

    Volume 89, Issue 5, May 2014, Pages: 517–523, Alberto Alvarez-Larrán, Beatriz Bellosillo, Arturo Pereira, Ana Kerguelen, Juan Carlos Hernández-Boluda, Luz Martínez-Avilés, Concepción Fernández-Rodríguez, Montse Gómez, Luis Lombardía, Anna Angona, Águeda Ancochea, Alicia Senín, Raquel Longarón, Blanca Navarro, María Collado and Carlos Besses

    Version of Record online : 21 FEB 2014, DOI: 10.1002/ajh.23676

  3. You have free access to this content
    The role of serum erythropoietin level and jak2 v617f allele burden in the diagnosis of polycythaemia vera

    British Journal of Haematology

    Volume 167, Issue 3, November 2014, Pages: 411–417, Àgueda Ancochea, Alberto Álvarez-Larrán, Cristian Morales-Indiano, Francesc García-Pallarols, Luz Martínez-Avilés, Anna Angona, Alicia Senín, Beatriz Bellosillo and Carles Besses

    Version of Record online : 18 JUL 2014, DOI: 10.1111/bjh.13047

  4. You have free access to this content
    The JAK2V617F mutation and thrombosis

    British Journal of Haematology

    Volume 143, Issue 3, November 2008, Pages: 307–320, S. K. Austin and J. R. Lambert

    Version of Record online : 30 MAY 2008, DOI: 10.1111/j.1365-2141.2008.07258.x

  5. You have free access to this content
    Molecular diagnostics of myeloproliferative neoplasms

    European Journal of Haematology

    Volume 95, Issue 4, October 2015, Pages: 270–279, Stephen E. Langabeer, Hajnalka Andrikovics, Julia Asp, Beatriz Bellosillo, Serge Carillo, Karl Haslam, Lasse Kjaer, Eric Lippert, Olivier Mansier, Elisabeth Oppliger Leibundgut, Melanie J. Percy, Naomi Porret, Lars Palmqvist, Jiri Schwarz, Mary F. McMullin, Susanne Schnittger, Niels Pallisgaard, Sylvie Hermouet and on behalf of the MPN&MPNr-EuroNet

    Version of Record online : 18 MAY 2015, DOI: 10.1111/ejh.12578

  6. JAK2 46/1 haplotype is associated with JAK2 V617F – positive myeloproliferative neoplasms in Brazilian patients

    International Journal of Laboratory Hematology

    Volume 37, Issue 5, October 2015, Pages: 654–660, L. C. Macedo, B. C. Santos, S. Pagliarini-e-Silva, K. B. B. Pagnano, C. Rodrigues, F. C. Quintero, M. E. Ferreira, E. C. Baraldi, E. P. Ambrosio-Albuquerque, A. M. Sell and J. E. L. Visentainer

    Version of Record online : 11 MAY 2015, DOI: 10.1111/ijlh.12380

  7. You have full text access to this Open Access content
    The JAK kinase inhibitor CP-690,550 supresses the growth of human polycythemia vera cells carrying the JAK2V617F mutation

    Cancer Science

    Volume 99, Issue 6, June 2008, Pages: 1265–1273, Taghi Manshouri, Alfonso Quintás-Cardama, Roberto H. Nussenzveig, Amos Gaikwad, Zeev Estrov, Josef Prchal, Jorge E. Cortes, Hagop M. Kantarjian and Srdan Verstovsek

    Version of Record online : 28 JUN 2008, DOI: 10.1111/j.1349-7006.2008.00817.x

  8. Hematopoietic clonal dominance, stem cell mutations, and evolutionary pattern of JAK2V617F allele burden in polycythemia vera

    European Journal of Haematology

    Volume 94, Issue 3, March 2015, Pages: 251–257, Anna Angona, Alberto Alvarez-Larrán, Beatriz Bellosillo, Luz Martínez-Avilés, Laura Camacho, Concepción Fernández-Rodríguez, Silvia Pairet, Raquel Longarón, Águeda Ancochea, Alicia Senín, Lourdes Florensa and Carles Besses

    Version of Record online : 13 SEP 2014, DOI: 10.1111/ejh.12425

  9. Somatic Mutations in Polycythaemia Vera and Other Philadelphia Chromosome Negative Myeloproliferative Neoplasms

    Standard Article

    eLS

    Lukasz P Gondek and Jerry L Spivak

    Published Online : 17 DEC 2012, DOI: 10.1002/9780470015902.a0024249

  10. You have free access to this content
    Experimental therapeutics for patients with myeloproliferative neoplasias

    Cancer

    Volume 117, Issue 4, 15 February 2011, Pages: 662–676, Meetu Agrawal, Ravin J. Garg, Jorge Cortes, Hagop Kantarjian, Srdan Verstovsek and Alfonso Quintas-Cardama

    Version of Record online : 4 OCT 2010, DOI: 10.1002/cncr.25672

  11. You have full text access to this Open Access content
    Molecular drug targets in myeloproliferative neoplasms: mutant ABL1, JAK2, MPL, KIT, PDGFRA, PDGFRB and FGFR1

    Journal of Cellular and Molecular Medicine

    Volume 13, Issue 2, February 2009, Pages: 215–237, Ayalew Tefferi

    Version of Record online : 23 OCT 2008, DOI: 10.1111/j.1582-4934.2008.00559.x

  12. You have free access to this content
    Clinical correlates of JAK2V617F allele burden in essential thrombocythemia

    Cancer

    Volume 109, Issue 11, 1 June 2007, Pages: 2279–2284, Jaya Kittur, Ryan A. Knudson, Terra L. Lasho, Christy M. Finke, Naseema Gangat, Alexandra P. Wolanskyj, Chin-Yang Li, Wenting Wu, Rhett P. Ketterling, Animesh Pardanani and Ayalew Tefferi

    Version of Record online : 17 APR 2007, DOI: 10.1002/cncr.22663

  13. You have free access to this content
    Molecular diagnosis of the myeloproliferative neoplasms: UK guidelines for the detection of JAK2 V617F and other relevant mutations

    British Journal of Haematology

    Volume 160, Issue 1, January 2013, Pages: 25–34, Anthony J. Bench, Helen E. White, Letizia Foroni, Anna L. Godfrey, Gareth Gerrard, Susanna Akiki, Abida Awan, Ian Carter, Andrea Goday-Fernandez, Stephen E. Langabeer, Tim Clench, Jordan Clark, Paul A. Evans, David Grimwade, Anna Schuh, Mary F. McMullin, Anthony R. Green, Claire N. Harrison and Nicholas C. P. Cross

    Version of Record online : 11 OCT 2012, DOI: 10.1111/bjh.12075

  14. Resveratrol selectively induces apoptosis in malignant cells with the JAK2V617F mutation by inhibiting the JAK2 pathway

    Molecular Nutrition & Food Research

    Volume 59, Issue 11, November 2015, Pages: 2143–2154, Ly Quoc Trung, J. Luis Espinoza, Dao T. An, Nguyen Hoang Viet, Kazuya Shimoda and Shinji Nakao

    Version of Record online : 16 SEP 2015, DOI: 10.1002/mnfr.201500166

  15. You have free access to this content
    The JAK2 V617F mutation in patients with cerebral venous thrombosis

    Journal of Thrombosis and Haemostasis

    Volume 10, Issue 6, June 2012, Pages: 998–1003, S. M. PASSAMONTI, E. BIGUZZI, M. CAZZOLA, F. FRANCHI, F. GIANNIELLO, P. BUCCIARELLI, D. PIETRA, P. M. MANNUCCI and I. MARTINELLI

    Version of Record online : 31 MAY 2012, DOI: 10.1111/j.1538-7836.2012.04719.x

  16. You have free access to this content
    Phospho-STAT5 and phospho-Akt expression in chronic myeloproliferative neoplasms

    British Journal of Haematology

    Volume 147, Issue 4, November 2009, Pages: 495–506, Lizz F. Grimwade, Lisa Happerfield, Colin Tristram, Gary McIntosh, Mark Rees, Anthony J. Bench, Elaine M. Boyd, Marie Hall, Amy Quinn, Nigel Piggott, Paul Scorer, Mike A. Scott and Wendy N. Erber

    Version of Record online : 31 AUG 2009, DOI: 10.1111/j.1365-2141.2009.07870.x

  17. You have free access to this content
    Occurrence of the JAK2 V617F mutation in patients with peripheral arterial disease

    American Journal of Hematology

    Volume 90, Issue 1, January 2015, Pages: E17–E21, Axel Muendlein, Elena Kinz, Klaus Gasser, Andreas Leiherer, Philipp Rein, Christoph H. Saely, Harald Grallert, Annette Peters, Peter Fraunberger, Heinz Drexel and Alois H. Lang

    Version of Record online : 20 NOV 2014, DOI: 10.1002/ajh.23874

  18. The JAK2 V617F allele burden in essential thrombocythemia, polycythemia vera and primary myelofibrosis – impact on disease phenotype

    European Journal of Haematology

    Volume 79, Issue 6, December 2007, Pages: 508–515, Thomas Stauffer Larsen, Niels Pallisgaard, Michael Boe Møller and Hans Carl Hasselbalch

    Version of Record online : 28 AUG 2007, DOI: 10.1111/j.1600-0609.2007.00960.x

  19. You have free access to this content
    Diagnostic value of JAK2 V617F somatic mutation for myeloproliferative cancer in 49 488 individuals from the general population

    British Journal of Haematology

    Volume 160, Issue 1, January 2013, Pages: 70–79, Camilla Nielsen, Henrik S. Birgens, Børge G. Nordestgaard and Stig E. Bojesen

    Version of Record online : 1 NOV 2012, DOI: 10.1111/bjh.12099

  20. You have free access to this content
    Modulation of JAK2 V617F allele burden dynamics by hydroxycarbamide in polycythaemia vera and essential thrombocythaemia patients

    British Journal of Haematology

    Volume 152, Issue 4, February 2011, Pages: 413–419, Carlos Besses, Alberto Álvarez-Larrán, Luz Martínez-Avilés, Sergi Mojal, Raquel Longarón, Antonio Salar, Lourdes Florensa, Sergi Serrano and Beatriz Bellosillo

    Version of Record online : 10 JAN 2011, DOI: 10.1111/j.1365-2141.2010.08467.x